MiR-143-3p inhibited airway epithelial cell epithelial mesenchymal transition as well as lung fibroblast extracellular matrix production by downregulating Smad3. Therefore, miR-143-3p may be a promising target to reduce airway remodeling in asthma.
[Pulmonary Pharmacology & Therapeutics]